A Population-based Study of Drug Exposures and Adverse Pregnancy Outcomes in China (DEEP)

CompletedOBSERVATIONAL

Enrollment

564,760

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

December 31, 2021

Study Completion Date

November 1, 2022

Conditions

PregnancyCongenital MalformationDrug Exposure

Interventions

DRUG

chemicals drugs, biological products, patent Chinese Medicines, Chinese herbs

medication (i.e., chemicals drugs, biological products, patent Chinese Medicines, Chinese herbs ) exposure through the pregnancy life course

Trial Locations (1)

Xiamen Health and Medical Big Data Center, Xiamen

All Listed Sponsors

collaborator

Xiamen Health Commission

UNKNOWN

collaborator

Xiamen Health and Medical Big Data Center

UNKNOWN

lead

West China Hospital

OTHER

NCT05620056 - A Population-based Study of Drug Exposures and Adverse Pregnancy Outcomes in China (DEEP) | Biotech Hunter | Biotech Hunter